Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - disodium edetate, quantity: 3 g - injection, powder for - excipient ingredients: ethanol absolute - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - disodium edetate, quantity: 3 g - injection, powder for - excipient ingredients: - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - disodium edetate dihydrate 0.1%{relative}; polidronium chloride 0.005%{relative} (plus 10% excess); polysorbate 80 0.005%{relative}; polyvinyl alcohol 0.75%{relative} - contact lens solution - 0.1% w/v - active: disodium edetate dihydrate 0.1%{relative} polidronium chloride 0.005%{relative} (plus 10% excess) polysorbate 80 0.005%{relative} polyvinyl alcohol 0.75%{relative} excipient: dibasic sodium phosphate dihydrate hydrochloric acid hypromellose monobasic sodium phosphate dihydrate purified water sodium chloride sodium hydroxide

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

allergan new zealand ltd - disodium edetate dihydrate 0.1%{relative}; octoxinol 0.035%{relative} (0.05%w/v of a 70%w/w solution); potassium sorbate 0.147%{relative} - contact lens solution - active: disodium edetate dihydrate 0.1%{relative} octoxinol 0.035%{relative} (0.05%w/v of a 70%w/w solution) potassium sorbate 0.147%{relative} excipient: borax boric acid hydrochloric acid hyetellose purified water sodium chloride sodium hydroxide

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

allergan new zealand ltd - disodium edetate dihydrate 0.2%{relative}; octoxinol 0.142%; potassium sorbate 0.13% - contact lens solution - active: disodium edetate dihydrate 0.2%{relative} octoxinol 0.142% potassium sorbate 0.13% excipient: boric acid hydrochloric acid hyetellose purified water sodium chloride sodium hydroxide

Nyuzilandi - Kiingereza - Ministry for Primary Industries

dermcare-vet (nz) pty ltd - poly(hexamethylene biguanide) hydrochloride; disodium edetate dihydrate - poly(hexamethylene biguanide) hydrochloride 2 g/litre; disodium edetate dihydrate 1.2 g/litre - antimicrobial

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - interferon alfa-2b 15 miu/ml - solution for injection - 18 miu - active: interferon alfa-2b 15 miu/ml excipient: dibasic sodium phosphate disodium edetate dihydrate metacresol monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - intron a redipen is used in the treatment of: · hairy cell leukaemia in splenectomised or non-splenectomised patients; · chronic myelogenous leukaemia;

Malta - Kiingereza - Medicines Authority

gambro lundia ab - disodium phosphate, dihydrate, magnesium chloride, hexahydrate, sodium chloride, sodium hydrogen, carbonate, potassium chloride - solution for haemodialysis, solution for haemofiltration - disodium phosphate dihydrate 0.187 gram(s)/litre ; magnesium chloride hexahydrate 3.05 gram(s)/litre ; sodium chloride 7.01 gram(s)/litre ; sodium hydrogen carbonate 2.12 gram(s)/litre ; potassium chloride 0.314 gram(s)/litre - blood substitutes and perfusion solutions

Marekani - Kiingereza - NLM (National Library of Medicine)

sciele pharma, inc. - ceftibuten dihydrate (unii: 62f4443rwp) (ceftibuten - unii:iw71n46b4y) - ceftibuten dihydrate 400 mg - cedax (ceftibuten) is indicated for the treatment of individuals with mild-to-moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below (see dosage and administration and clinical studies sections). acute bacterial exacerbations of chronic bronchitis due to haemophilus influenzae (including β-lactamase-producing strains), moraxella catarrhalis (including β-lactamase-producing strains), or streptococcus pneumoniae (penicillin-susceptible strains only). note: in acute bacterial exacerbations of chronic bronchitis clinical trials where moraxella catarrhalis was isolated from infected sputum at baseline, ceftibuten clinical efficacy was 22% less than control. acute bacterial otitis media due to haemophilus influenzae (including β-lactamase-producing strains), moraxella catarrhalis (including β-lactamase-producing strains), or streptococcus pyogenes. note: although ceftibuten used empirically was equivalent to comparators in the treatme

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 5 g; disodium edetate, quantity: 3 g - injection, powder for - excipient ingredients: ethanol absolute - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons